Special Issues-10-02-2015 | LCGC Supplements

Special Issues

Monoclonal Antibodies and Biosimilars — A Selection of Analytical Tools for Characterization and Comparability Assessment

October 02, 2015

Features

33

10

With the top-selling mAbs evolving out of patent there has been a growing interest in the development of biosimilars. In demonstrating comparability to the originator product, biosimilar developers are confronted with an enormous analytical challenge. This article presents a selection of state-of-the-art analytical tools for mAb characterisation and comparability assessment.

Vol 28 No s10 LCGC Europe October 2015 Advances in Biopharmaceutical Analysis Supplement PDF

October 02, 2015

Issue PDF

33

10

Click the title above to open the LCGC Europe October 2015 Advances in Biopharmaceutical Analysis Supplement, Vol 28, No s10, in an interactive PDF format.